can you die from tirzepatide linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s Weight loss drugs can halve

Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy

This means up to 90% absorption compared to the 10-20% you get from traditional supplements

References FDA Prescribing Information Zepbound, Mounjaro NEJM SURMOUNT and SURPASS trial publications Published tirzepatidesemaglutide head-to-head trial MedlinePlus tirzepatide Disclaimer Although the information on this page is based on available educational research and product information, it is provided for informational purposes only and is not medical advice

Contraindications for non-diabetic GLP-1 use include pregnancy, personal history of thyroid cancer, and certain gastrointestinal disorders

A.Johnson JrJ

Research shows that behavior change alone rarely maintains GLP-1 weight loss after stoppingapproximately 70% of weight returns despite best efforts